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ABSTRACT 
Objective: The objective of the present research was to improve physicochemical and micromeritic properties of Olmesartan Medoxomil (OLM), 
BCS class II antihypertensive drug by loading in Chitosan (CH) microparticles. 
Methods: The 32 full factorial design was assigned for microparticles prepared by single emulsion technique method using CH, a natural polymer 
and Glutaraldehyde (GA) as cross linking agent. Developed microparticles were characterized for Micromeritic properties, morphology by Scanning 
Electron Microscopy (SEM), drug entrapment efficiency, in vitro drug release, and interaction studies Fourier transfer infrared spectroscopy (FTIR) 
& Differential Scanning Calorimetry (DSC), drug crystallinity study by X-ray diffractometry (XRD) & DSC.  
Results: Maximum entrapment efficiency was found 61.76% for maximal CH and lower GA concentration. Saturation solubility of microparticles was 
increased by 13.74 times to that of pure OLM. FTIR showed compatibility between drug and polymer. XRD, DSC and SEM studies confirmed reduction in 
crystallinity of drug. It led to increase in dissolution profile of the drug and showed 92.61% of drug release in 120 min. These microparticle preparations 
also helped in improving micromeritic properties like bulk density, tapped density, the angle of repose, Hausner’s ratio and Carr’s index. 
Conclusion: The results obtained in the present work demonstrate the potential use of CH to modulate physicochemical and micromeritic 
properties of OLM especially obtaining significant improvement in dissolution rate.  




yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-carboxylic acid (5-
methyl-2-oxo-1,3-dioxol-4-yl) methyl ester; 5-Methyl-2-oxo-1,3-
dioxol-4-yl) methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-((4-(2-
(2H-tetrazol-5-yl))phenyl)phenyl)methyl)imidazole-4-carboxylate) 
is a pro drug that works by blocking the binding of angiotensin II to 
the AT1 receptor. As a result of this blockage, OLM reduces 
vasoconstriction and the secretion of aldosterone. This lowers blood 
pressure by producing vasodilation, and decreasing peripheral 
resistance. OLM drug particles have the crystalline nature and 
possess poor physiological properties like wettability, solubility, 
flow property, dissolution rate etc. Hence, it belongs to BCS class II of 
drug. It has low bioavailability i.e. about 26% [1]. CH (2-Amino-2-
deoxy-(1, 4)-b-D-glucopyranan) is the name applied to deacetylated 
chitins [2]. The degree of deacetylation necessary to obtain a soluble 
product must be greater than 80–85%. It has been received 
increasing interest as natural pharmaceutical excipient because of 
naturally obtained good biocompatible, biodegradable, 
mucoadhesive and non-toxic properties [3]. CH is cross linked into 
particulate drug delivery system with cross linking agents like 
formaldehyde, GA, sodium tripolyphosphate etc [4-6]. 
Several researchers have tried to increase dissolution profile and 
flow properties of OLM by solid dispersion, crystallo-co-
agglomeration, nanoemulsion technique etc. by using synthetic 
polymers [7-9]. Main focus of this work is to improve the aqueous 
solubility and in turn the dissolution profile along with micromeritic 
and flow properties of the OLM using natural polymer CH and single 
emulsion technique using GA as cross linking agent. Among the 
various approaches available to increase the aqueous solubility of 
drugs, preparation of microparticles is a novel approach.  
MATERIALS AND METHODS 
Materials 
All the chemicals and reagents required for the present research 
work has been obtained from authentic supplier and were of 
analytical grade. The API, OLM has been obtained as the gift sample 
from Lupin Research Park, Pune, India. CH was obtained from 
Research-Lab Fine Chem. Industries, Mumbai, India. Paraffin, GA, 
tween 80, acetone, methanol and hydrochloric acid were purchased 
from loba chemie, Mumbai, India. Triple distilled water obtained 
after distillation from triple distillation apparatus at Govt. College of 
Pharmacy Karad was used throughout the experiment. 
Methods 
Experimental design 
A 32 level full-factorial design includes 9 full factorial design points 
with the help of Design Expert version 8.0.7.1. According to the 
model, total 9 experiments were performed. This design involves 
dependent variables and independent or controlled variables A and 
B. In the present study, experiment was conducted considering 
concentration of CH and GA as independent variables. The 
dependent variables were Y1; percentage entrapment efficiency and 
Y2; percentage drug release. 
Preparation of microparticles 
The trial batches were prepared using various concentrations of the 
CH and GA. The concentrations for the factorial design were finalized 
based on the evaluation of trial batches. In the preliminary study, CH 
in acetic acid solution was used in the range of 1-5% and out of them 
4% CH solution showed solid and free flowing microparticles. GA (1-
3%) was used as the cross linking agent. During trial, microparticles 
containing 1:0.5-1:1.5 of drug: CH ratio as well as 1-3% of GA were 
prepared and evaluated for percentage entrapment efficiency and 
percentage drug release pattern. The microparticles of trial batches 
were prepared by the single emulsion technique using overhead 
rotator stirrer with 1500 rpm speed and constant cross linking time 
[10-12]. 
In this work, CH solution (aqueous phase) was prepared using a 2% 
aqueous acetic acid solution. Drug was added in aqueous solution of 
CH. Dispersion medium (oil phase) was prepared by using liquid 
paraffin and an emulsifier Tween-80. Then CH solution (aqueous 
phase) was poured into the dispersion medium (oil phase) drop 
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wise. The dispersion medium was stirred using overhead stirrer 
during drop wise addition of an aqueous phase. A predetermined 
amount and concentrations of GA was added into the dispersion 
medium after 10 min. The CH microspheres were collected by 
filtration and washed with acetone/water solution (1:3 of volume 
ratio) to remove liquid paraffin. The microparticles were dried in an 
oven at 40 °C for 24 h [13].  
From the trial batches, the 32 full factorial designs, coded values and 
formulation table (table 1, 2 and 3) were employed to optimize the 
concentration of CH and GA. 
 
Table 1: Factorial design batches 
Batches % CH % GA 
1 -1 1 
2 -1 0 
3 1 -1 
4 1 1 
5 0 1 
6 0 0 
7 0 -1 
8 -1 -1 
9 1 0 
 
Table 2: Coded values of factorial design batches 
Variables used Coded levels 
-1 1 
% CH 33 60 
% GA 1 3 
 
Determination of drug content, percentage loading capacity (% 
LC) and percentage entrapment efficiency (% EE) of prepared 
microparticles  
Drug content was determined by dissolving 10 mg samples of 
microparticle in 10 ml of methanol and the volume was adjusted to 
100 ml with methanol. The solution was filtered through Whatmaan 
filter paper no. 41, suitably diluted and absorbance was measured at 
256 nm using double beam UV spectrophotometer (Shimadzu 1800, 











Table 3: Formulation table 
S. No. Batch code OLM: CH ratio % GA % CH solution in acetic acid solution Time period (min.) 
1 A1 1:0.5 1 4 30 
2 A2 1:0.5 2 4 30 
3 A3 1:0.5 3 4 30 
4 B1 1:1 1 4 30 
5 B2 1:1 2 4 30 
6 B3 1:1 3 4 30 
7 C1 1:1.5 1 4 30 
8 C2 1:1.5 2 4 30 
9 C3 1:1.5 3 4 30 
 
Saturation solubility studies of prepared microparticles 
Saturation solubility studies were performed in triplicate according 
to the method reported by Higuchi and Connors. Excess of pure drug 
and microparticles were added to 10 ml of 0.1 N HCl solution and 
distilled water taken in screw cap tube and shaken for 24 h in the 
rotary flask shaker at 100 rpm at room temperature to achieve the 
equilibrium. Appropriate aliquots were then withdrawn and filtered 
through Whatmaan filter paper no. 41 and analysed 
spectrophotometrically at 256 nm. The results obtained from 
saturation solubility studies were statistically validated [15-16]. 
Fourier Transform Infrared Spectroscopy (FT-IR) 
The FT-IR spectra of OLM microspheres was obtained on JASCO V-
530 FTIR-4100 spectrometer, (Japan) having Spectra Manager II 
software and scanned over the range 400-4000 cm-1. Dry KBr (50 
mg) was finely ground in the mortar and samples (1-2 mg) were 
subsequently added and gently mixed.  
X-ray Diffractometry (XRD) 
The XRD data of OLM and microparticles were recorded on a Philips 
Analytic X-Ray-PW 3710 (Philips, Almelo, The Netherlands) 
diffractometer having PAN alytical’s XRD software and tube anode 
Cr over the interval 10–90 °/2θ under the following set of 
conditions: the Generator tension (voltage): 40 kV and Generator 
current: 25 mA. 
Differential scanning calorimetry (DSC) 
Thermal analysis of the samples was performed on a Shimadzu DSC 
60 with CLASS-Agent Data Management Software. Samples (3-5 mg) 
were crimped in non-hermetic aluminium pans with lids and 
scanned from-50 to 250 °C at a heating rate of 20 °C/min under a 
continuously purged dry nitrogen atmosphere (flow rate 20 
ml/min). The instrument was equipped with a refrigerated cooling 
system. 
Scanning electron microscopy 
The surface morphology of microparticles and pure drug was 
analysed using scanning electron microscope (SEM-Jeol Instrument 
JSM-6360, Japan) after sputter coating with platinum. 
In-vitro dissolution study 
The drug release studies of microparticles were carried out by using 
USP Type II dissolution apparatus (paddle) DT1000 (Labindia, 
India). The dissolution studies were conducted in 900 ml dissolution 
medium 0.1N HCl buffer pH 1.2 for 2 h; as the average gastric 
emptying time is about 2 h, thermo stated at 37±0.5 °C and stirred at 
50 rpm. Aliquots were taken at appropriate interval and filtered 
samples were estimated for OLM using UV spectrophotometer 
(Shimadzu 1800, Japan) at 256 nm. After collecting the sample, the 
dissolution medium was replenished with the same volume of fresh 
medium. 
Micromeritic properties 
The flow properties of pure drug and microparticles were 
determined in terms of the angle of repose, Bulk density, tapped 
density, Carr's Index and Hausner’s ratio. 
Angle of repose 
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Bulk density 
The bulk density was calculated from graduated cylinder method. A 
sample of about 50 g was carefully transferred into 100 ml graduated 
cylinder and the cylinder dropped onto a hard wooden surface three 






It is the reciprocal of bilk density and has importance in packaging of 






Proceed as described above for the determination of the bulk 
volume. Secure the cylinder in the holder. Carry out 100 taps on the 
same sample and read the tapped volume to the nearest graduated 















RESULTS AND DISCUSSION 
Ofloxacin loaded CH-GA microparticles were prepared by single 
emulsion technique for alveolar microphage delivery system via 
pulmonary inhalation [13]. Different batches from factorial design of 
microparticles were prepared by single emulsion technique. It was 
observed that less than 4% concentration of CH solution was not 
able to form microparticles and as concentration increases, it was 
difficult to form microparticles. Hence, CH solution concentration 
was kept constant but as the ratio of drug: CH increases upto 1:1, 
drug content increases and then decreases. GA concentration was 
selected on the basis of drug release from the microparticle 
formulations. 
Practical yield, percentage loading capacity and percentage 
entrapment efficiency 
Ju-Hwan Park et al. found increase in entrapment efficiency of the 
ofloxacin microparticles with CH as compared with powdered 
ofloxacin and microparticles of ofloxacin with PLGA. CH 
microparticles were prepared with water in oil single emulsion 
technique with GA as a cross linking agent [13]. 
From the table 4, it was observed that as CH concentration 
increases, there was decrease in practical yield of microparticles 
as well as decrease in % loading capacity due to the density and 
viscosities of microparticles were goes on increasing with CH 
[17].  
Viscosity increased with CH concentration, so % entrapment 
efficiency goes on increasing. Percentage of GA also affected the 
percentage entrapment efficiency. It was observed that, as % GA 
increases, there was the decrease in % entrapment efficiency. 
 
Table 4: Practical yield, percentage loading capacity and percentage entrapment efficiency 
S. No. Batches Practical yield (%) % loading capacitya  % entrapment efficiency-a 
1 A1 39.58 32.71±0.45 49.06±0.61 
2 A2 45.00 29.01±0.78 43.18±1.13 
3 A3 35.00 26.64±0.79 39.95±1.56 
4 B1 56.25 28.62±0.53 57.24±0.44 
5 B2 47.50 28.61±1.24 57.22±0.46 
6 B3 60.13 23.51±1.91 47.01±0.17 
7 C1 76.00 24.70±1.65 61.76±0.70 
8 C2 56.22 23.77±0.95 59.37±0.85 
9 C3 90.00 23.65±1.15 59.12±1.11 
a SD = Standard deviations, n=3 
 
 
Fig. 1: Study of %EE by surface methodology: 1) 3D surface plot 2) contour plot 
 
Study of percentage entrapment efficiency by response surface 
methodology 
Equation (1) of the formulations containing CH and GA for the 
studied response variables are expressed as Equation 
%EE = 54.42+8.01 * A-3.66 * B+1.62 * A * B-1.75 * A2-0.90 * B2 ……. (1) 
Where, A and B represents the effect of variables i.e. concentration 
of CH and GA concentration respectively. All the polynomial 
equations were found to be statistically significant, as determined 
using ANOVA, as per the provision of Design Expert version 8.0.7.1. 
The Model F-value of 12.12 in above equation implies the model was 
significant. P value was found to be 0.0333 (P<0.05) indicate model 
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Design points below predicted value
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X1 = A: CH conc.
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concentration of the CH and GA on the % entrapment efficiency of the 
formulation. The 3D surface plot and counter plot clearly indicate that % 
EE was increased with increase in concentration of CH and decreased 
with increase in GA concentration. From the formulations, it was 
observed that the maximum entrapment efficiency was obtained with 
the formulations C1.  
Solubility study 
The table 5 shows that OLM has shown very low solubility in 0.1 N 
HCl solution and water. Hence, the aim of this study was to enhance 
the dissolution rate of drug, by enhancing solubility of drug. It was 
observed that all formulations of micro particle by using CH as a 
polymer help to improve the saturation solubility of OLM. Batch C2 
showed maximum solubility among the other batches. It was 
observed that CH microparticles enhance the solubility of OLM by 
13.743 times than pure drug OLM but it didn’t clearly indicate the 
effect of concentration of CH and GA on saturation solubility study. 
 
Compatibility study by FT-IR 
 
Fig. 2: FTIR of A: OLM; B: CH; C: physical mixture; D: micro particle 
The fig. 2 shows the FT-IR spectrum of OLM and polymer i.e. CH. It 
showed characteristic peaks for OLM at 3454 cm-1, 1832 cm-1, 1707 
cm-1 and 1632 cm-1 corresponding to stretching vibration of 
secondary amines (–NH-), stretching vibration of the conjugation of 
oxygen on C=O group, stretching vibration for C=O and C=C present 
in conjugation of C=O with α, β C=C group respectively. FT-IR 
spectrum of CH showed characteristic peak at 3435 cm-1 and 1384 
cm-1corresponding to stretching vibration of secondary amines (–
NH-) and conjugation of oxygen on C-O group in six member ring. 
Other peaks were observed at 2920.66 cm-1 and 1122.37 cm-1 and 
were assigned to stretching vibrations for C-H and C-O-C.  
All these peaks are present in physical mixture and microparticles of 
OLM and CH. Hence, it revealed absence of chemical interaction between 
API and polymer and chemical compatibility with each others. 
 
Differential scanning calorimetry 
 
Fig. 3: DSC of A: OLM; B: A1; C: B1; D: C1; E: C2 
 
Table 5: Saturation solubility 
S. No. Batch Solubility in dist. Watera (µg/ml) Conc. In 0.1 N HCl a (µg/ml) 
1. Drug 3.5±0.44 5.53±0.28 
2 A1 35.8±0.17 30.79±0.38 
3 A2 26.0±0.52 51.42±0.43 
4 A3 31.3±0.46 16.74±0.37 
5 B1 37.2±0.46 35.47±0.29 
6 B2 21.7±0.85 22.84±0.69 
7 B3 21.0±0.96 22.63±0.19 
8 C1 32.7±0.79 21.84±0.18 
9 C2 48.1±0.62 14.68±0.68 
10 C3 29.3±0.35 26.32±0.35 
a SD = Standard deviations. n=3 
 
The melting point of a compound is a fundamental physical property 
determined for the purpose of characterization or purity identification 
of a compound. The DSC showed in fig. 3 corresponding value of sharp 
endotherm at melting point. The DSC of pure drug OLM had shown the 
sharp endotherm at 188.47 °C with high endothermic peak area 
indicating crystalline anhydrous nature. While that of microparticles 
showed absence of sharp peak revealed amorphization and/or drug 
complexation with polymer. It revealed that area of endotherm peak 
was totally decreased. Hence, it is confirmed that decrease in 
crystallinity of drug OLM in formulation with CH. 
Lowering of the drug melting temperature and a concomitant 
reduction of enthalpy attributes to a partial drug amorphization 
that occurred during microparticle preparation [19]. Same 
behavior was observed in CH carrying microparticle but it didn’t 
reveal the effect of concentrations on the amorphization of 
microparticles. 
X-ray diffractometry (XRD) 
XRD pattern was used to confirm amorphous nature of the 
generated microparticles. XRD is a powerful technique for 
determining the presence of crystalline structure in drug and 
generation or reduction of crystal form during the process of 
formation of microparticles [20]. As shown in fig. 4, unique XRD 
patterns showed peak intensities of drug and microparticles with CH 
at various diffraction angles (2θ). It can be seen that the 
microparticles exhibited spectra with same peak positions 
(patterns) compared to drug. Further, the relative intensities of their 
diffraction peaks were modified which might be attributed to the 
different crystals and arrangement of molecules. The relative degree 
of crystallinity (RDC) is the comparative study of crystallinity of 





If the RDC value is greater than 1, it represents crystallinity of 
microparticles increases than drug and if it is less than 1 then it 
represents decrease in crystallinity. Table 6 showed the RDC of 
microparticles were considerably lower than 1. Thus, it is cleared 
that there is reduction in crystallinity of OLM in microparticles 
which attributes to improvement in dissolution profile of samples 
and can be justified by dissolution results [12, 16]. 
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Fig. 4: XRD of A: OLM; B: A1; C: A2; D: A3; E: B1; F: B2; G: B3; I: 
C1; J: C2; K: C3. 
 
Scanning Electron Microscopy 
SEM analysis shown in fig. 5 evidenced the fine particular OLM and 
irregular shape of microparticles. The rough and porous surfaces were 
observed in microparticles, indicating the presence of CH polymer. 
Plain OLM drug showed a slightly spherical shape and larger clumps of 
particles in SEM image, but when loaded with CH in microparticles, 
there was a slight improvement in spherical shape and size. 
In-vitro dissolution study 
CH has properties of dissolution rate enhancer of drugs poorly 
soluble in water. Carbamazepine was entrapped into CH 
microspheres by spray drying method contributed to an 
improvement of its dissolution/release rate [21].  
Fig. 6 demonstrates the dissolution profiles of drug and 
microparticles. OLM showed 24.63% drug release within 120 min, 
because it has low wettability due to fine nature confirmed from 
SEM. According to DSC and XRD data, it was ascertained increase 
in amorphous nature of the formulation. Hence, all microparticles 
improved dissolution of OLM. The increase in release rate was 
dependent on CH concentration and GA concentration but in 
opposite fashion. Microparticles with highest CH concentration 
and lowest GA concentration showed maximum release rate. 
Hydrophilic nature of CH was responsible for enhancement of 
dissolution of OLM and GA helped for increase in wettability of 
microparticles by forming tough complex.  
Hence, increasing GA concentration retarded the release rate as 
shown in formulations. So A3, B3 and C3 showed less drug release 
profile as compared with other formulations but C1 showed 
highest drug release 92.61% within 120 min. This is because of 
increased amount of CH in drug and CH ratio and decrease in 
concentration of GA from 3% to 1%. 
 
Table 6: RDC of microparticles at respective 2θ value 
 (2θ) A1 A2 A3 B1 B2 B3 C1 C2 C3 
21.7382 0.156 0.162 0.131 0.137 0.131 0.117 0.142 0.100 0.172 
24.5964 0.228 0.250 0.200 0.198 0.210 0.192 0.215 0.201 0.239 
 
Scanning electron microscopy 
 
Fig. 5: SEM of OLM and microparticles 
 
 
Fig. 6: Dissolution profile study 
Study of % DR by response surface method 
From the study of response variables following equation (2) is 
generated for the formulations containing CH and GA 
%DR = 83.82+2.45 * A-3.75 * B-1.0 * A * B+0.63 * A2-0.20 * B2. . . (2) 
Where, A and B represents the effect of variables i.e. Concentration 
of CH and GA concentration respectively. All the polynomial 
equations were found to be statistically significant, as determined 
using ANOVA, as per the provision of Design Expert 8.0.7.1. The 
Model F-value of 10.78 in above equation implies the model is 
significant. P value was found to be 0.0392 (P<0.05) which indicates 
model terms A and B are significant [18]. 
Fig. 7 shows the profound effect of concentration of the CH and GA 
on the % drug release of the formulation. The counter plot clearly 
indicates that the % DR is increased with increase in concentration 
of CH and GA. From the formulations, it was observed that the 
maximum % DR was obtained with the formulation C1. 
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Fig. 7: Study of %DR by surface methodology 1) 3D surface plot 2) contour plot 
 
Micromeritic properties 
Micromeritic properties of microparticles presented in table 7 
showed increase in flow property of microparticles with reducing an 
angle of repose within 23 °-30 ° as compared to drug. If value of 
angle of repose is high, particles are cohesive and if it is low, 
particles are non-cohesive or free flowing. The tapped density of 
particles indicates packing capacity. The bulk density and tapped 
density of all the samples fell in the range of 0.32–0.42 g/cm3. 
Bulkiness of formulations was slightly varied with respect to drug. 
The value of Carr’s Index and Hausner’s ratio was in conformity with 
an increase in flow rate of all the samples. The value of Carr’s index 
and Hausner’s ratio of the microparticles was found to be decreased 
than OLM [22]. 
  
Table 7: Study of micromeritic properties 











Drug 38.31±0.006 0.33±0.06 3.03±0.59 0.50±0.010 34.00±11.35 1.52±0.27 
A1 29.25±0.11 0.34±0.01 2.94±0.05 0.40±0.009 15.00±2.06 1.18±0.03 
A2 28.81±0.01 0.33±0.01 3.03±0.08 0.40±0.009 17.50±2.71 1.21±0.04 
A3 29.25±0.74 0.38±0.01 2.63±0.09 0.42±0.002 9.52±2.90 1.11±0.04 
B1 28.37±0.04 0.32±0.01 3.13±0.06 0.37±0.012 13.51±3.34 1.16±0.05 
B2 27.92±0.10 0.36±0.01 2.78±0.06 0.39±0.005 7.69±3.03 1.08±0.04 
B3 27.92±0.10 0.39±0/01 2.56±0.06 0.41±0.004 4.88±2.46 1.05±0.03 
C1 28.81±0.07 0.37±0.01 2.70±0.08 0.41±0.006 9.76±1.34 1.11±0.02 
C2 27.47±0.06 0.34±0.05 2.94±0.37 0.41±0.075 17.07±3.81 1.21±0.05 
C3 27.92±0.04 0.38±0.02 2.63±0.11 0.40±0.005 5.00±5.10 1.05±0.06 
* SD = standard deviation, n=3 
 
Stability study 
All the formulations as shown in table 8 were examined for their 
accelerated stability study at 40 °C±2 °C temperatures and 75%±5% 
relative humidity for about two months. The formulations were 
assessed for the drug present in formulations.  
The microparticles were found to be stable during the study period.  
 
Table 8: Accelerated Stability study of drug and all batches 
Batches % Drug present* 
Time=10 d Time=30 d Time=45 d Time=60 d 
Drug 99.87±1.24 99.09±1.06 100.01±1.3 99.78±1.09 
A1 99.05±0.68 99.08±0.71 100.04±1.03 99.13±0.75 
A2 98.67±1.01 99.35±0.79 99.98±1.3 99.04±0.97 
A3 99.76±1.06 99.22±0.68 98.59±0.98 100.04±0.94 
B1 99.01±0.98 99.55±0.97 98.98±0.68 99.34±0.93 
B2 99.89±0.87 98.89±0.92 99.28±0.94 99.28±1.00 
B3 100.12±0.95 100.09±0.89 99.46±0.83 99.83±1.25 
C1 99.38±1.00 99.78±0.87 100.06±0.88 99.92±1.03 
C2 99.31±1.01 99.94±1.23 99.29±0.87 98.95±0.99 
C3 99.49±0.99 99.07±1.06 99.04±0.99 99.69±1.00 
* SD = standard deviation, n=3 
 
CONCLUSION 
OLM microparticles were prepared using CH as polymer and GA as a 
cross linking agent. The formulation of microparticles helps to 
modify the physicochemical properties of OLM. The prepared 
microparticles didn’t show any chemical interaction between OLM 
and CH, confirmed by FT-IR study. The study of XRD, DSC and 
solubility showed increase in amorphous nature and solubility of the 
formulations. Surface morphology study showed entrapment of OLM 
in CH. The in-vitro dissolution study indicated release of drug in the 
upper GI tract and confirmed enhancement of dissolution profile of 
OLM microparticles compared to pure drug. On the basis of these 
results, it could be concluded that, pharmaceutical micro particulate 
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as an alternative and effective approach for manipulation of 
physicochemical and micromeritic properties of OLM. 
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